ImmunoPrecise Antibodies Ltd. (IPA) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
18/25
Growth 5
Margin 4
Expansion 4
Platform 2
Financial 3
latest quarter score
Earnings Reports
- 18
- 20